Grand River Selected for Operation Warp Speed Efforts
The CDMO will offer capacity for manufacturing and distributing COVID-19 vaccines and therapeutics at its Grand Rapids, MI, fill/finish facility.
Grand River Aseptic Manufacturing (GRAM), a parenteral contract development and manufacturing organization (CDMO), announced on August 6, 2020 that it has been chosen by the US Department of Health and Human Services and the US Department of Defense to support the US government’s Operation Warp Speed efforts by offering capacity for manufacturing and distributing COVID-19 vaccines and therapeutics.
Under the terms of the partnership, the government will reserve fill/finish capacity on a commercial filling line for use by federal partners that are developing COVID-19 vaccines or therapeutic treatments, a GRAM press release said. The company plans to use its 60,00-ft2 large-scale fill/finish facility located in Grand Rapids, MI, to aid in the pandemic efforts.
“We are extremely honored to be chosen to serve our country and help respond to the demands and challenges presented by the COVID-19 pandemic,” said Tom Ross, president and CEO of GRAM, in the press release. “As a homegrown company with a strong culture built on teamwork and accountability, our team will confidently deliver the safest and highest-quality solutions that will ultimately be life-saving for the American people.”
VERAXA and Voyager to Create Combined Business for Advancing Pipeline of Next-Gen Cancer Therapies
April 23rd 2025The proposed business combination would create a publicly traded, clinical-stage biopharmaceutical company that will focus on developing a pipeline of next-generation cancer therapies.
Thermo Fisher Opens Advanced Therapies Collaboration Center in California
April 18th 2025The 6000-square-foot facility will provide cell therapy developers the support they need to transition to CGMP manufacturing, and an expanded footprint of the new center is expected to open in Philadelphia later in 2025.
